البحث | ruh.org.tr

إعلان مُمول

Pooja Chincholkar أضاف وظيفة جديدة Öz Farkındalık
2025-09-26 05:30:55 -

Primary Sclerosing Cholangitis Market Overview: Trends, Challenges, and Forecast 2025 –2032
Detailed Analysis of Executive Summary Primary Sclerosing Cholangitis Market Size and Share CAGR Value The Global Primary Sclerosing Cholangitis Market size was valued at USD 337 Million in 2024 and is expected to reach USD 661 million by 2032, at a CAGR of 7.7% during the forecast period An international Primary Sclerosing Cholangitis Market research...

0 التعليقات 0 المشاركات 941 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Anuj Mrfr أضاف وظيفة جديدة Meditasyon ve Farkındalık
2026-01-23 09:09:17 -

Primary Sclerosing Cholangitis Market: Will 2026 "Bile Acid Modulators" Finally Make Ursodeoxycholic Acid Obsolete?
A major 2026 trend in the liver disease sector is the challenge to traditional first-line treatments. In 2026, the market is identifying "Second-Generation Bile Acid Modulators" like norUDCA and FXR agonists as critical value-shifter for the Primary Sclerosing Cholangitis Market, offering targeted relief that standard Ursodeoxycholic Acid (UDCA) has failed to provide. This 2026 movement is...

0 التعليقات 0 المشاركات 461 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

إعلان مُمول